98 related articles for article (PubMed ID: 21207323)
1. [Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience].
Stepan H; Schaarschmidt W; Jank A; Verlohren S; Kratzsch J
Z Geburtshilfe Neonatol; 2010 Dec; 214(6):234-8. PubMed ID: 21207323
[TBL] [Abstract][Full Text] [Related]
2. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients.
Verlohren S; Herraiz I; Lapaire O; Schlembach D; Moertl M; Zeisler H; Calda P; Holzgreve W; Galindo A; Engels T; Denk B; Stepan H
Am J Obstet Gynecol; 2012 Jan; 206(1):58.e1-8. PubMed ID: 22000672
[TBL] [Abstract][Full Text] [Related]
3. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
[TBL] [Abstract][Full Text] [Related]
4. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.
Verlohren S; Galindo A; Schlembach D; Zeisler H; Herraiz I; Moertl MG; Pape J; Dudenhausen JW; Denk B; Stepan H
Am J Obstet Gynecol; 2010 Feb; 202(2):161.e1-161.e11. PubMed ID: 19850276
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia.
Hirokoshi K; Maeshima Y; Kobayashi K; Matsuura E; Sugiyama H; Yamasaki Y; Masuyama H; Hiramatsu Y; Makino H
Nephron Clin Pract; 2007; 106(1):c43-50. PubMed ID: 17409768
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy.
McElrath TF; Lim KH; Pare E; Rich-Edwards J; Pucci D; Troisi R; Parry S
Am J Obstet Gynecol; 2012 Nov; 207(5):407.e1-7. PubMed ID: 22981320
[TBL] [Abstract][Full Text] [Related]
7. [Can pre-eclampsia be predicted?].
Rosseland NL; Barbero ML; Staff A
Tidsskr Nor Laegeforen; 2011 May; 131(8):806-7. PubMed ID: 21556080
[No Abstract] [Full Text] [Related]
8. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia.
Verlohren S; Herraiz I; Lapaire O; Schlembach D; Zeisler H; Calda P; Sabria J; Markfeld-Erol F; Galindo A; Schoofs K; Denk B; Stepan H
Hypertension; 2014 Feb; 63(2):346-52. PubMed ID: 24166751
[TBL] [Abstract][Full Text] [Related]
9. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
[TBL] [Abstract][Full Text] [Related]
10. Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1/ PlGF Ratio in Singleton Pregnancies.
Herraiz I; Llurba E; Verlohren S; Galindo A;
Fetal Diagn Ther; 2018; 43(2):81-89. PubMed ID: 28719896
[TBL] [Abstract][Full Text] [Related]
11. Urinary sFlt-1 and PlGF levels are strongly correlated to serum sFlt-1/PlGF ratio and serum PlGF in women with preeclampsia.
Hebert-Schuster M; Ranaweera T; Fraichard C; Gaudet-Chardonnet A; Tsatsaris V; Guibourdenche J; Lecarpentier E
Pregnancy Hypertens; 2018 Apr; 12():82-83. PubMed ID: 29674205
[No Abstract] [Full Text] [Related]
12. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
[TBL] [Abstract][Full Text] [Related]
13. Early onset preeclampsia and second trimester serum markers.
Lambert-Messerlian GM; Palomaki GE; Neveux LM; Chien E; Friedman A; Rosene-Montella K; Hayes M; Canick JA
Prenat Diagn; 2009 Dec; 29(12):1109-17. PubMed ID: 19842088
[TBL] [Abstract][Full Text] [Related]
14. Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia.
Schiettecatte J; Russcher H; Anckaert E; Mees M; Leeser B; Tirelli AS; Fiedler GM; Luthe H; Denk B; Smitz J
Clin Biochem; 2010 Jun; 43(9):768-70. PubMed ID: 20206155
[TBL] [Abstract][Full Text] [Related]
15. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
Chen Q; Zhao Y; Zou L; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
[TBL] [Abstract][Full Text] [Related]
16. A Review of Angiogenic Imbalance in HIV-Infected Hypertensive Disorders of Pregnancy.
Padayachee S; Moodley J; Naicker T
Curr Hypertens Rep; 2019 Jul; 21(9):69. PubMed ID: 31342170
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating interleukin-17 levels in preeclampsia.
Molvarec A; Czegle I; Szijártó J; Rigó J
J Reprod Immunol; 2015 Nov; 112():53-7. PubMed ID: 26232149
[TBL] [Abstract][Full Text] [Related]
18. Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia--the PreOS study protocol.
Hund M; Verhagen-Kamerbeek W; Reim M; Messinger D; van der Does R; Stepan H
Hypertens Pregnancy; 2015 Feb; 34(1):102-15. PubMed ID: 25629903
[TBL] [Abstract][Full Text] [Related]
19. THE CORRELATION BETWEEN MARKERS OF SYSTEMIC INFLAMMATION AND ANGIOGENIC MARKERS IN PRE-ECLAMPSIA.
Mihălceanu E; Nemescu D; Gavriluţ M; Dimitriu DC; Pangal A; Onofriescu M
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):473-83. PubMed ID: 26204655
[TBL] [Abstract][Full Text] [Related]
20. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop.
McKeeman GC; Ardill JE; Caldwell CM; Hunter AJ; McClure N
Am J Obstet Gynecol; 2004 Oct; 191(4):1240-6. PubMed ID: 15507947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
